Rocío Gallego-Durán currently holds a post-doctoral position in the Institute of Biomedicine of Seville (IBiS), in the SeLiver Group led by Prof. Romero-Gómez. She graduated from the University of Seville with a Bachelor ́s degree in Biology, and in 2017 she completed her PhD in Molecular Biology and Clinical Research, Cum Laude with the International Mention, and she further obtained the Doctoral Extraordinary Award from the University of Seville in 2019. Rocío has a longstanding research interest in the development of non-invasive biomarkers for non-alcoholic fatty liver disease (NAFLD) diagnosis, as well as new therapeutic strategies with potential to be transferred to the bedside mainly based on epigenetic approaches. This is evidenced by the (co)-authorship of 42 peer-reviewed original papers and reviews. Rocío became a principal investigator of two competitive- funded projects, regarding novel biomarker discovery and therapies for NAFLD in both human and preclinical models. Besides, she is co-investigator in 11 national and international competitive-funded projects. She is also teaching in the Master of Biomedicine from University of Seville, and currently directing one doctoral thesis, with defense date on 2021. She is an active member of several scientific associations and networks (AEEH, EASL, AASLD,CIBEREHD), and has been invited speaker in different scientific conferences, as well as rewiever for a number of 8 peer-reviewed journals.